Moore Capital Management’s Nuvalent NUVL Stock Holding History

Moore Capital Management’s Portfolio NUVL Stock Details NUVL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.94M	Buy	+40,000	New	+$4.3M	0.07%	234

Other funds holding NUVL

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

Moore Capital Management's NUVL Position: Q1 2024 in Review

Moore Capital Management sold out of Nuvalent (NUVL) in Q1 2024, closing a stake of 2,730 shares — an estimated $201K sold.

Moore Capital Management first reported a position in NUVL in Q3 2023 and held it in 2 quarters. The position peaked at $1.15M in Q3 2023. 180 funds tracked by Wall St. Rank hold NUVL as of Q1 2024.

Moore Capital Management reported no remaining Nuvalent position as of Q1 2024 after selling out during the quarter.
Moore Capital Management sold 2,730 Nuvalent shares in Q1 2024, an estimated $201K.
Moore Capital Management first reported a position in Nuvalent in Q3 2023 and held it in 2 quarters.
Moore Capital Management's Nuvalent position peaked at $1.15M in Q3 2023.
180 funds tracked by Wall St. Rank held Nuvalent as of Q1 2024.

Based on Moore Capital Management's 13F filing for Q1 2024, filed 15 May 2024.